Trevena, Inc. (TRVN) Stock Price & Analysis
Trevena, Inc. (TRVN) closed at USD 0.07 on Wednesday, October 14, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.07; the Oct 14, 2026 session ranged USD 0.01–0.01 on volume of 210 shares. Market capitalization is $57,010, with a 52-week range of USD 0–1.5 (PNK). Source: Nexqual, retrieved October 16, 2026 at 06:43 UTC.
Also available as compact Markdown for AI agents: nexqual.com/TRVN.md
Key facts (TRVN)
- Analysts: None.
- Total return with dividends: 1Y +450.0% vs S&P 500 +18.1%; 5Y -100.0% vs S&P 500 +85.1%.
Analysts (TRVN)
Consensus None.
Total return (dividends reinvested) (TRVN)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | +450.0% | -100.0% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +455.8% | -84.3% |
| Volatility (annualized) | 879.6% | 374.2% |
| Max drawdown | -98.0% (Oct 2025→Sep 2026) | -100.0% (Oct 2021→Sep 2026) |
Key Statistics (as of October 16, 2026 at 06:43 UTC)
| Price | USD 0.07 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.07 |
| Open | USD 0.01 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0 – 1.5 |
| Volume | 210 shares |
| Market Cap | $57,010 |
| Exchange | PNK |
Technical Analysis (TRVN)
Nexqual's technical model rates TRVN "BUY" based on 5 bullish and 3 bearish signals across 92 daily candles, as of October 16, 2026 at 06:43 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 94.98 (overbought) |
| vs SMA50 | Above (USD 0.01) |
| MACD | 0.01 (positive) |
Analyst Ratings (TRVN)
Wall Street analysts rate TRVN "None", per Nexqual as of October 16, 2026 at 06:43 UTC.
| Consensus Rating | None |
|---|
Earnings (TRVN)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2024-09-30 | USD -5.79 vs est -7.75 ▲ beat |
| 2024-06-30 | USD -5.75 vs est -10.13 ▲ beat |
| 2024-03-31 | USD -9 vs est -11.75 ▲ beat |
| 2023-12-31 | USD -28.25 vs est -9.5 ▼ miss |
Source: Nexqual, October 16, 2026 at 06:43 UTC.
Financials & Fundamentals (TRVN)
| Total Revenue | $546,000 |
|---|---|
| Revenue Growth (latest quarter, YoY) | +57.20% |
| Gross Margin | -190.48% |
| Operating Margin | -1970.67% |
| Profit Margin | +0.00% |
| Current Ratio | 2.42 |
| Total Cash | $13.46M |
| Total Debt | $37.56M |
Source: Nexqual, October 16, 2026 at 06:43 UTC.
Financial Health Score (TRVN)
Nexqual rates Trevena, Inc.'s overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 06:43 UTC.
| Growth | Strong — Revenue +57% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $13M cash vs $38M debt |
| Cash Flow | Weak — Operating cash flow -$27M (TTM) |
| Efficiency | Mixed — No data |
Ownership (TRVN)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +11.00% |
| Shares Outstanding | 863,788 |
| Float | 859,072 |
| Short % of Float | +8.33% |
Source: Nexqual, October 16, 2026 at 06:43 UTC.
Leadership (TRVN)
Trevena, Inc. is led by Carrie L. Bourdow (age 62), President, CEO & Chairman, per Nexqual as of October 16, 2026 at 06:43 UTC.
| President, CEO & Chairman | Carrie L. Bourdow (age 62) |
|---|---|
| Vice President of Marketing | Michael Catalano |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals, Inc. | USD 87.97 | ▲ 1.57% |
| BLTE | Belite Bio, Inc | USD 152.62 | ▲ 0.49% |
| IOVA | Iovance Biotherapeutics, Inc. | USD 14.72 | ▲ 1.52% |
| PRAX | Praxis Precision Medicines, Inc | USD 248.24 | ▲ 2.01% |
| IONS | Ionis Pharmaceuticals, Inc. | USD 44.12 | ▲ 4.11% |
| SYRE | Spyre Therapeutics, Inc. | USD 80.1 | ▼ 0.44% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 06:43 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt